Sign in

CIK 0001728328 · <br>Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Tickers
INM MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3

Securities

  • INM Common stock Nasdaq
  • MTRI Common Stock Nasdaq
  1. SC 13G Stake Amended Statement of Ownership
  2. 8-K Event Shareholder rights changed · Regulation FD disclosure · Other events
  3. 8-K Event Delisting notice · Regulation FD disclosure
  4. DEF 14A Proxy Proxy Statement
  5. 8-K Event Regulation FD disclosure
  6. DEFA14A Proxy Proxy Materials
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Regulation FD disclosure
  9. 424B3 Offering Prospectus
  10. 8-K Event Regulation FD disclosure
  11. 10-K Report Annual Report
  12. 8-K Event Other events
  13. 8-K Event Delisting notice · Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Regulation FD disclosure
  16. 4 Insider Changes in Ownership
  17. 8-K Event Regulation FD disclosure
  18. 8-K Event Material agreement
  19. 424B3 Offering Prospectus
  20. 8-K Event Regulation FD disclosure

Page 9 of 27 · 533 filings